Clinical trial Recruiting at 1 site Interventional Ages 18 and up Women only

Deep muscle relaxation and a low-residue diet to improve the surgical view during vNOTES hysterectomy

Official title: Effect of Deep Neuromuscular Blockade and a Preoperative Low-Residue Diet on Intra-operative Surgical Field Conditions During Vaginal Natural Orifice Transluminal Endoscopic Surgery (vNOTES) Hysterectomy: A 2×2 Factorial, Assessor-Blinded Randomized Controlled Trial

Run by Fatih Sultan Mehmet Training and Research Hospital · NCT07730970 · Data updated 2026-11-12

This trial tests whether a preoperative low-residue diet and deeper muscle relaxation help doctors see better during a vaginally performed hysterectomy for benign conditions.

More Uterine Prolapse trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexWomen only
Enrollment160 (estimated)
SponsorFatih Sultan Mehmet Training and Research Hospital
Academic / other
Locations3 sites (Istanbul, KARTAL and 2 other locations)
StatusRecruiting
StartedJuly 1, 2026
Main results expectedJuly 25, 2027
Study endsSeptember 1, 2027
Registry record updatedJuly 30, 2026
Trial IDNCT07730970 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Women aged 18 or older undergoing hysterectomy for benign indications and deemed suitable for vNOTES by the surgeon.

Probably not a fit

Patients for whom deep neuromuscular blockade or a low-residue diet does not improve surgical visibility, or who have contraindications to vNOTES, may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

In this randomized 2x2 factorial study, adult women scheduled for benign-indication hysterectomy via vNOTES are assigned to one of four groups: standard relaxation with or without a preoperative low-residue diet, and deep neuromuscular blockade with or without the diet. The primary outcome uses objective video-based scoring to determine the lowest intra-abdominal pressure at which the surgical field is adequate, with secondary assessment for optimal visibility. Deep relaxation targets a post-tetanic count of 1–2 with full reversal before extubation, while standard relaxation uses a train-of-four count of 1–2. The study excludes those with cancer or conditions that could complicate the vNOTES approach, and all participants receive sugammadex for reversal. Field visualization is assessed at multiple pressure steps using blinded evaluators and a predefined scoring index adapted for vNOTES.

Why it matters

Potential benefit: If successful, the approach could improve surgical visibility, potentially making vNOTES hysterectomy safer and more efficient.

How similar studies have gone: Prior work with objective visualization indices in laparoscopy supports the feasibility of similar approaches, but this exact factorial design in vNOTES is novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adult women (aged 18 years or older) scheduled for hysterectomy for a benign (non-cancer) indication.
* Judged suitable for the vNOTES approach by the operating surgeon.
* Able to understand the study and provide written informed consent.

Exclusion Criteria:

* Suspected or known gynaecological malignancy.
* Conditions expected to make the approach or the field assessment non-standard (e.g., anticipated dense pelvic adhesions or severe endometriosis, a contraindication to vNOTES, or an obliterated cul-de-sac).
* Any medical reason why deep neuromuscular blockade or sugammadex would be unsafe (defined with the anaesthesia team).
* Any medical reason why a low-residue diet would be unsuitable.
* Inability to give informed consent.

Where it's running

  • Acibadem Kartal Hospital
    Istanbul, Kartal, Turkey (Türkiye)
    Recruiting
  • Kartal Dr. Lütfi Kırdar Şehir Hastanesi
    Istanbul, Kartal, Turkey (Türkiye)
    Active not recruiting
  • Kütahya Şehir Hastanesi
    Kütahya, Kütahya, Turkey (Türkiye)
    Active not recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.